Literature DB >> 22782839

C-Glycosphingolipids with an exo-methylene substituent: stereocontrolled synthesis and immunostimulation of mouse and human natural killer T lymphocytes.

Zheng Liu1, Amy N Courtney, Leonid S Metelitsa, Robert Bittman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22782839      PMCID： PMC3438909          DOI： 10.1002/cbic.201200374

Source DB:  PubMed          Journal:  Chembiochem        ISSN： 1439-4227            Impact factor:   3.164


× No keyword cloud information.
  31 in total

1.  Synthesis and biological evaluation of truncated α-galactosylceramide derivatives focusing on cytokine induction profile.

Authors:  Tetsuya Toba; Kenji Murata; Junko Futamura; Kyoko Nakanishi; Bitoku Takahashi; Naohiro Takemoto; Minako Tomino; Takashi Nakatsuka; Seiichi Imajo; Megumi Goto; Takashi Yamamura; Sachiko Miyake; Hirokazu Annoura
Journal:  Bioorg Med Chem       Date:  2012-03-20       Impact factor: 3.641

2.  Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of alpha-galactosylceramides.

Authors:  Karl O A Yu; Jin S Im; Alberto Molano; Yves Dutronc; Petr A Illarionov; Claire Forestier; Nagatoshi Fujiwara; Isa Arias; Sachiko Miyake; Takashi Yamamura; Young-Tae Chang; Gurdyal S Besra; Steven A Porcelli
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-18       Impact factor: 11.205

3.  A modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells.

Authors:  Yang Liu; Randal D Goff; Dapeng Zhou; Jochen Mattner; Barbara A Sullivan; Archana Khurana; Carlos Cantu; Eugene V Ravkov; Chris C Ibegbu; John D Altman; Luc Teyton; Albert Bendelac; Paul B Savage
Journal:  J Immunol Methods       Date:  2006-03-06       Impact factor: 2.303

4.  The crystal structure of human CD1d with and without alpha-galactosylceramide.

Authors:  Michael Koch; Victoria S Stronge; Dawn Shepherd; Stephan D Gadola; Bini Mathew; Gerd Ritter; Alan R Fersht; Gurdyal S Besra; Richard R Schmidt; E Yvonne Jones; Vincenzo Cerundolo
Journal:  Nat Immunol       Date:  2005-07-10       Impact factor: 25.606

5.  NKT TCR recognition of CD1d-α-C-galactosylceramide.

Authors:  Onisha Patel; Garth Cameron; Daniel G Pellicci; Zheng Liu; Hoe-Sup Byun; Travis Beddoe; James McCluskey; Richard W Franck; A Raúl Castaño; Youssef Harrak; Amadeu Llebaria; Robert Bittman; Steven A Porcelli; Dale I Godfrey; Jamie Rossjohn
Journal:  J Immunol       Date:  2011-09-30       Impact factor: 5.422

6.  Design of a potent CD1d-binding NKT cell ligand as a vaccine adjuvant.

Authors:  Xiangming Li; Masakazu Fujio; Masakazu Imamura; Douglass Wu; Sandhya Vasan; Chi-Huey Wong; David D Ho; Moriya Tsuji
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-02       Impact factor: 11.205

7.  Synthesis of C-glycoside analogues of α-galactosylceramide via linear allylic C-H oxidation and allyl cyanate to isocyanate rearrangement.

Authors:  Zheng Liu; Robert Bittman
Journal:  Org Lett       Date:  2012-01-10       Impact factor: 6.005

8.  A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells.

Authors:  K Miyamoto; S Miyake; T Yamamura
Journal:  Nature       Date:  2001-10-04       Impact factor: 49.962

9.  Use of the NEO strategy (Nucleophilic addition/Epoxide Opening) for the synthesis of a new C-galactoside ester analogue of KRN 7000.

Authors:  Aline Banchet-Cadeddu; Agathe Martinez; Stéphane Guillarme; Véronique Parietti; Fanny Monneaux; Eric Hénon; Jean-Hugues Renault; Jean-Marc Nuzillard; Arnaud Haudrechy
Journal:  Bioorg Med Chem Lett       Date:  2011-02-17       Impact factor: 2.823

10.  Α-galactosylceramide analogs with weak agonist activity for human iNKT cells define new candidate anti-inflammatory agents.

Authors:  Gabriel Bricard; Manjunatha M Venkataswamy; Karl O A Yu; Jin S Im; Rachel M Ndonye; Amy R Howell; Natacha Veerapen; Petr A Illarionov; Gurdyal S Besra; Qian Li; Young-Tae Chang; Steven A Porcelli
Journal:  PLoS One       Date:  2010-12-17       Impact factor: 3.240
View more
  3 in total

1.  Synthesis and biological activities of C-glycosides of KRN 7000 with novel ceramide residues.

Authors:  Ahmad S Altiti; Xiaojing Ma; Lixing Zhang; Yi Ban; Richard W Franck; David R Mootoo
Journal:  Carbohydr Res       Date:  2017-03-06       Impact factor: 2.104

2.  The Crotylation Way to Glycosphingolipids: Synthesis of Analogues of KRN7000.

Authors:  Ahmad S Altiti; Stewart Bachan; David R Mootoo
Journal:  Org Lett       Date:  2016-08-25       Impact factor: 6.005

3.  Versatile Glycosyl Sulfonates in β-Selective C-Glycosylation.

Authors:  Jesse Ling; Clay S Bennett
Journal:  Angew Chem Int Ed Engl       Date:  2020-02-03       Impact factor: 15.336
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.